NXTC stock

NextCure  Inc (NXTC) financials · $11.5M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

NextCure  Inc (NXTC) $11.5M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$57.6M-$59.7M
Net Income-$55.8M-$55.7M
EPS (Diluted)-$19.65-$1.99
Cached annual balance sheet
LineFY2025FY2024
Total Assets$50.2M$80.9M
Current Assets$43.7M$71.8M
Cash & Equivalents$26.0M$27.7M
PP&E$3.27M$5.46M
Total Liabilities$15.2M$15.4M
Current Liabilities$10.6M$9.57M
Shareholders' Equity$34.9M$65.5M
Retained Earnings-$436.0M-$380.1M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$49.6M-$40.8M
CapExN/A$474.0K
Investing Cash Flow$25.6M$55.3M
Financing Cash Flow$22.3M$144.0K
Net Change in Cash-$1.75M$14.6M
Free Cash FlowN/A-$41.3M
These statements as JSON? API free 100/day

FAQ

What is NXTC P/E and revenue?

NextCure  Inc (NXTC) $11.5M cap.

What is NXTC revenue?

NXTC income-statement cache has no revenue figure yet.

Is NXTC profitable?

NextCure  Inc last cached net income is -$55.8M (FY2025).

What are NXTC total assets?

NextCure  Inc last cached total assets are $50.2M (FY2025).

What is NXTC free cash flow?

No cached cash-flow row for NXTC yet.

Not investment advice. Cached statements, not a live tape.